Work

Correction to: A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies

Year: 2023

Type: erratum

Source: Investigational New Drugs

DOI: 10.1007/s10637-023-01369-0

Authors: Danny N. Khalil, Isabel Prieto González-Albo, Lee Rosen, Tom Lillie, Andrea Stacey, Lola Parfitt, Gerald A. Soff

Institutions: Memorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy, Weill Cornell Medicine, Ronald Reagan UCLA Medical Center, UCLA Medical Center, University of Miami Health System, Sylvester Comprehensive Cancer Center

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4376132015

Cites:

Cited by:

Related to: 10